Morgan Stanley
PMD

Morgan Stanley’s Psychemedics Corporation PMD Stock Holding History

Morgan Stanley’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,001
Closed -$6.93K – 8167
2024
Q3 		$6.93K Hold
3,001
– – ﹤0.01% 6818
2024
Q2 		$7.26K Sell
3,001
-500
-14% -$1.27K ﹤0.01% 6765
2024
Q1 		$10.3K Sell
3,501
-3,501
-50% -$11.1K ﹤0.01% 6695
2023
Q4 		$20.7K Buy
7,002
+2,502
+56% +$6.67K ﹤0.01% 6650
2023
Q3 		$17.9K Sell
4,500
-12,042
-73% -$53.7K ﹤0.01% 6521
2023
Q2 		$75.4K Buy
16,542
+272
+2% +$1.38K ﹤0.01% 6058
2023
Q1 		$85.4K Buy
16,270
+4,414
+37% +$24.5K ﹤0.01% 6074
2022
Q4 		$58.1K Sell
11,856
-7,876
-40% -$46.5K ﹤0.01% 6226
2022
Q3 		$127K Buy
19,732
+575
+3% +$3.7K ﹤0.01% 5960
2022
Q2 		$122K Buy
19,157
+14,141
+282% +$90.6K ﹤0.01% 6172
2022
Q1 		$35K Buy
5,016
+4
+0.1% +$28 ﹤0.01% 6876
2021
Q4 		$35K Sell
5,012
-1,166
-19% -$9.33K ﹤0.01% 6977
2021
Q3 		$52K Hold
6,178
– – ﹤0.01% 6704
2021
Q2 		$43K Sell
6,178
-700
-10% -$4.91K ﹤0.01% 6735
2021
Q1 		$43K Buy
6,878
+1,200
+21% +$7.95K ﹤0.01% 6417
2020
Q4 		$29K Buy
5,678
+2,500
+79% +$10.8K ﹤0.01% 6342
2020
Q3 		$14K Hold
3,178
– – ﹤0.01% 6173
2020
Q2 		$18K Sell
3,178
-4,398
-58% -$24.6K ﹤0.01% 6037
2020
Q1 		$46K Buy
7,576
+532
+8% +$4.48K ﹤0.01% 5493
2019
Q4 		$64K Buy
7,044
+618
+10% +$5.71K ﹤0.01% 5791
2019
Q3 		$59K Sell
6,426
-574
-8% -$4.88K ﹤0.01% 5649
2019
Q2 		$71K Buy
7,000
+2,284
+48% +$25.9K ﹤0.01% 5470
2019
Q1 		$66K Sell
4,716
-4,412
-48% -$75.8K ﹤0.01% 5548
2018
Q4 		$145K Sell
9,128
-7,898
-46% -$136K ﹤0.01% 5411
2018
Q3 		$320K Sell
17,026
-21,031
-55% -$419K ﹤0.01% 5237
2018
Q2 		$733K Sell
38,057
-4,567
-11% -$92.6K ﹤0.01% 4837
2018
Q1 		$911K Sell
42,624
-9,302
-18% -$193K ﹤0.01% 4608
2017
Q4 		$1.07M Sell
51,926
-174
-0.3% -$3.23K ﹤0.01% 4497
2017
Q3 		$960K Buy
52,100
+18,567
+55% +$409K ﹤0.01% 4459
2017
Q2 		$837K Sell
33,533
-3,520
-9% -$74K ﹤0.01% 4497
2017
Q1 		$743K Sell
37,053
-19,503
-34% -$428K ﹤0.01% 4591
2016
Q4 		$1.4M Buy
56,556
+27,503
+95% +$616K ﹤0.01% 4208
2016
Q3 		$576K Buy
29,053
+26,628
+1,098% +$494K ﹤0.01% 4437
2016
Q2 		$33K Hold
2,425
– – ﹤0.01% 5680
2016
Q1 		$33K Sell
2,425
-650
-21% -$7.45K ﹤0.01% 5763
2015
Q4 		$31K Hold
3,075
– – ﹤0.01% 5894
2015
Q3 		$31K Sell
3,075
-10,912
-78% -$127K ﹤0.01% 5900
2015
Q2 		$207K Sell
13,987
-57,831
-81% -$901K ﹤0.01% 5213
2015
Q1 		$1.19M Buy
71,818
+13,976
+24% +$218K ﹤0.01% 3996
2014
Q4 		$876K Sell
57,842
-5,560
-9% -$80.7K ﹤0.01% 4255
2014
Q3 		$898K Buy
63,402
+1,368
+2% +$19.4K ﹤0.01% 4122
2014
Q2 		$879K Sell
62,034
-8,702
-12% -$132K ﹤0.01% 4159
2014
Q1 		$1.21M Sell
70,736
-3,014
-4% -$50K ﹤0.01% 3836
2013
Q4 		$1.08M Buy
73,750
+12,860
+21% +$177K ﹤0.01% 3881
2013
Q3 		$807K Buy
60,890
+9,699
+19% +$120K ﹤0.01% 3973
2013
Q2 		$550K Buy
+51,191
New +$575K ﹤0.01% 4195

Other funds holding PMD

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
SMP
Santa Monica Partners Palm Beach Gardens, Florida $179M AUM 19.18% 1-Year Est. Return

Morgan Stanley's PMD Position: Q4 2024 in Review

Morgan Stanley sold out of Psychemedics Corporation (PMD) in Q4 2024, closing a stake of 3,001 shares — an estimated $6.93K sold.

Morgan Stanley first reported a position in PMD in Q2 2013 and held it in 46 quarters. The position peaked at $1.4M in Q4 2016. 3 funds tracked by Wall St. Rank hold PMD as of Q4 2024.

  • Morgan Stanley reported no remaining Psychemedics Corporation position as of Q4 2024 after selling out during the quarter.
  • Morgan Stanley sold 3,001 Psychemedics Corporation shares in Q4 2024, an estimated $6.93K.
  • Morgan Stanley first reported a position in Psychemedics Corporation in Q2 2013 and held it in 46 quarters.
  • Morgan Stanley's Psychemedics Corporation position peaked at $1.4M in Q4 2016.
  • 3 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2024.

Based on Morgan Stanley's 13F filing for Q4 2024, filed 14 Feb 2025.